Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by Meir Hospital, Kfar Saba, Israel
Sponsor:
Information provided by (Responsible Party):
Dr. Sidney Ben Chetrit, Meir Hospital, Kfar Saba, Israel
ClinicalTrials.gov Identifier:
NCT01970280
First received: October 22, 2013
Last updated: October 25, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)